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Abstrad-This paper describes the mass distribution in
healthy subjects and dengue patients on the day of
defervescence of fever using bioelectrical impedance
analysis. A total of 223 healthy subjects (65 males and
158 females) and 210 dengue patients (I 19 males and
91 females) were studied. The ages for healthy
subjects vary between 14 and 60 years old with mean
age of 26.05 years while the ages for the dengue
patients vary between 12 and 83 years old with mean
age of 30.14 years. The parameters of mass
distribution investigated were body cell mass (BCM)
and extracellular mass (ECM). There were significant
difference between healthy subjects and dengue
patients for female in BCM and ECM beginning on
fever day 0 till fever day 4 (p<0.001). There were also
significant difference between healthy subjects and
dengue patients for male in BCM for fever day I till
fever day 3 and in ECM for all fever days (p<0.05).
On the other hand, both the mean BCM and ECM for
healthy and dengue groups for male were higher than
female. Bioelectrical Impedance Analysis is a useful
method to assess the changes of mass distribution in
dengue patients.
1. Introduction
Analysis of body composition is important aspect
of clinical research to assess the pathophysiology of
human health and diseases. Bioclectrical impedance is
a noninvasive, inexpensive, portable method of body
composition analysis, which is appealing for both
research and clinical practice [1]. Although
bioelectrical impedance has been validated in healthy
populations and certain disease states [2-5], it has not
been tested in evaluating mass distribution of the
dengue patients. This is important because previous
studies have shown that bioelectrical impedance is
sensitive in predicting and monitoring body cell mass
in HIV patients [6].
Bioelectrical impedance application in evaluating
mass distribution of the dengue patients is relatively
new. To date, no known literature describe the mass
distribution in Malaysian population.
In this study, we focused on the measurement of
mass distribution in bioelectrical impedance analysis
(BIA) for Malaysian healthy subjects and dengue
patients. The parameters for the mass distribution
investigated are body cell mass (BCM) and
extracellular mass (ECM).
2. Subjects and Methods
2.1. Subjects
The subjects are divided into 2 groups: Group 0 is
the control healthy subjects while Group I is the
dengue patients. Group 0 consists of a total of 223
volunteers with no past medical history. Subjects were
non-randomly volunteers, recruited through
advertisement in the University Malaya's monthly
news bulletin 'BERITA UM', internal posters
circulation, and internal University Malaya's email.
Some of the volunteers were from general public
during the University Malaya convocation exposition
2002 and the University Malaya Second College
Creative Week Open day 2002. On the other hand,
Group I consists of a total of 210 dengue patients aged
12 years old and above, serologically confirmed
dengue patients during their hospitalization in
University Kebansan Malaysia (HUKM) in the years
of 2001 and 2002 [71.
2.2. Method
For each subject, informed consent form was
obtained and anthropotnetrics measurements (height
and weight) were taken at admission. Demographic
data were recorded using standardized questionnaire
data collection forms designed for the study. All
subjects were abstained from eating and drinking for 4
hours and physical exercise for 12 hours prior to the
BIA measurement. These protocols were implemented
to ensure an accurate body composition result [8]. The
BIA safety measurements procedure and other safety
precautions were made known to the subjects.
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2.3 BIA Measurement
Subjects were asked to lie supine on their bed and
two electrodes were placed on the right hand, one at
the base of knuckles and another slightly above the
wrist joint. Another two electrodes were placed on the
right foot, one near the base of the toes and the other
slightly above the ankle joint. A constant current less
than ImA at a single frequency of 50kHz [8] was
injected to the base of the toes and the signal was pick-
up by the other two sensor electrodes (slightly above
the ankle and wrist joint).
Each measurement took approximately 3 minutes.
Bioelectrical impedance measurement was performed
with a biodynamic Model 450 bioimpedance analyzer,
from Biodynamic Corporation USA. The subject's
profile such as age, sex, height and weight were
entered to the BIA 450 analyzer. The analyzer directly
measures bioelectrical tissue conductivity and uses
regression analysis to compute the mass distribution
(BCM and ECM) and water compartments.
3. Statistical Analysis
The statistical analysis was performed using SPSS
statistical package version 12 for WINDOWS XP.
The clustered error bar chart displaying 95%
confidence interval of mass distribution was drawn.
Univariate Analysis of Variance (ANOVA) was used
to assess whether the mass distribution are
significantly different between the healthy subject and
dengue patients.
4. Results and Discussions
The BIA measurements have been conducted to
223 healthy subjects (65 males and 158 females) while
210 dengue patients (I19 males and 91 females). The
subjects' distribution with gender and groups is
illustrated in Figure 1.
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Figure 1: The subject's distribution with gender and groups.
For the healthy subjects, in the racial distribution,
the Malay contributes to 63.68% followed by Chinese
30.040/o, Indian 2.24% and others 4.04% while for the
dengue patients, the Malay contributes to 55.24%
followed by Chinese 28.570/o, Indian 7.14% and others
9.05%. The subjects' distribution with race and group
is illustrated in Figure 2. The ages of healthy subjects
vary between 14 and 60 years old with mean age of
26.05 years while the ages of the dengue patients vary
between 12 and 83 years old with mean age of 30.14
years.
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Figure 2: The subject's distribution with race and groups.
The clustered error bar chart displaying 95%
confidence interval of BCM and ECM for day after
fever defervesence with gender and groups were drawn
as shown in Figures 3 and 4, respectively. Univariate
Analysis of Variance (ANOVA) was used to estimate
the significantly different of mean value for mass
distribution between dengue and healthy subjects.
From in Figures 3 and 4, the overall significant value
for BCM and ECM between healthy and dengue
groups for female was p<0.001 while for male was
p<0.05.
From Figure 3, the mean BCM of dengue patients
for both gender were lower than the normal healthy
subjects beginning from fever day 0 till day 4. For
example, the mean ± standard errors of BCM for
female dengue patient on fever day I was 32.90±0.28
% which is lower than the control healthy subjects
35.53±0.19% (p<0.001). At the same time, the mean
value of both groups was higher in male than in
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female. The mean ± standard error of BCM for male
on fever day I was 42.01±0.43% which is higher than
in female (32.90±0.28%). There was no specific trend
of day effect in BCM for female dengue patient.
However, the mean value was increasing from fever
day 0 till day 2 while decreasing after fever day 2 for
male dengue patient (See table I).
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Figure 3: Confidence interval distribution ofBody Cell Mass
(BCM) for day after fever subsided with gender and groups.
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Figure 4: Confidence interval distribution of Extracellular
Mass (ECM) for day after fever subsided with gender and
groups.
On the other hand, the mean ECM of dengue
patients for both female and male were higher than the
normal healthy subjects beginning from fever day 0 till
day 4 (Figure 4). However, the mean ECM for both
groups were higher in male than in female, e.g. the
mean :1 standard error for healthy male was
41.95±0.53% which is higher than the female mean
value (38.90±0.31%). The mean ± standard errors of
ECM .for male dengue patient on fever day 2 was
43.70±0.45 % which is higher than the control healthy
subjects 41.95±0.53 % (p<0.05). There was no specific
trend of day effect in ECM for female dengue patient
However, the mean value was decreasing from fever
day 0 till day 3 (See table 1).
The ability to measure BCM would provide a
reference basis for the measurement of oxygen
consumption, caloric requirement, basal metabolic rate
and work perfonnance [9]. This study showed that the
mean value ofBCM in dengue patients was lower than
the healthy subjects. The results obtained were in
agreement with the depletion ofBCM in HIV infection
and critical level ofBCM must be maintained [101.
Table 1: The Body Cell Mass and Extracellular Mass mean
Classification Results for Gender and Groups
(Gender Coding; FEMALE=0, MALE=1)
Days No of Gender Mean ± Standard Error
Sample BCM (%) ECM (%)
0 45 0 33.20X035 41.35±0.58
} 771 0 32.90±028 41.30±0.46
2 63 0 3337±030 41.93±0.49
3 52 0 33.04±033 41.56±0.54
4 28 0 32.63±0.45 42.85±0.73
Control 158 0 35.53±0.19 38.90±0.31
0 62 1 42.42±0.51 -44.58±0.54
1 89 1 42.01±0.43 43.70±0.45
2 90 1 41.66±0.43 43.70±0.45
3 63 1 42.16±0.51 43.58±0.53
4 29 1 42.28±0.75 44.15±0.79
Control 65 1 43.63±0.50 41.95±0.53
5. Conclusion
The BIA technique provides a non-invasive, simple
to use, and reliable method to accurately monitor the
changes in mass distribution of dengue patients. The
finding indicates that dengue patients were affected in
their mass distribution. The mean BCM values of
dengue patients were lower than the normal healthy
subjects while the mean ECM values of dengue
patients were higher than the healthy subjects. These
values can be used as an indicator to monitor the daily
progress of the pathphysiology changes of the dengue
fever and other diseases.
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